Peptidyl‐prolyl cis/trans isomerase Pin1 regulates withaferin A‐mediated cell cycle arrest in human breast cancer cells. Issue 7 (16th April 2018) - Samanta, Suman K.
Abstract : We have reported previously that withaferin A (WA) prevents breast cancer development in mouse mammary tumor virus‐ neu (MMTV‐ neu ) transgenic mice, but the mechanism is not fully understood. Unbiased proteomics of the mammary tumors from control‐ and WA‐treated MMTV‐ neu mice revealed downregulation of peptidyl‐prolyl cis/trans isomerase (Pin1) protein by WA administration. The present study extends these findings to elucidate the role of Pin1 in cancer chemopreventive mechanisms of WA. The mammary tumor level of Pin1 protein was lower by about 55% in WA‐treated rats exposed to N ‐methyl‐ N‐ nitrosourea, compared to control. Exposure of MCF‐7 and SK‐BR‐3 human breast cancer cells to WA resulted in downregulation of Pin1 protein. Ectopic expression of Pin1 attenuated G2 and/or mitotic arrest resulting from WA treatment in both MCF‐7 and SK‐BR‐3 cells. WA‐induced apoptosis was increased by Pin1 overexpression in MCF‐7 cells but not in the SK‐BR‐3 cell line. In addition, molecular docking followed by mass spectrometry indicated covalent interaction of WA with cysteine 113 of Pin1. Overexpression of Pin1 C113A mutant failed to attenuate WA‐induced mitotic arrest or apoptosis in the MCF‐7 cells. Furthermore, antibody array revealed upregulation of proapoptotic insulin‐like growth factor binding proteins (IGFBPs), including IGFBP‐3, IGFBP‐4, IGFBP‐5, and IGFBP‐6, in Pin1 overexpressing MCF‐7 cells following WA treatment when compared to empty vector transfected control cells. These data support a crucial role of the Pin1 for mitotic arrest and apoptosis signaling by WA at least in the MCF‐7 cells.